-
4
-
-
0242684410
-
-
S. Mead et al., Science 300, 640 (2003).
-
(2003)
Science
, vol.300
, pp. 640
-
-
Mead, S.1
-
5
-
-
0029831213
-
-
J. Collinge, K. C. L. Sidle, J. Meads, J. Ironside, A. F. Hill, Nature 383, 685 (1996).
-
(1996)
Nature
, vol.383
, pp. 685
-
-
Collinge, J.1
Sidle, K.C.L.2
Meads, J.3
Ironside, J.4
Hill, A.F.5
-
6
-
-
0030820354
-
-
A. F. Hill et al., Nature 389, 448 (1997).
-
(1997)
Nature
, vol.389
, pp. 448
-
-
Hill, A.F.1
-
7
-
-
0030775632
-
-
M. E. Bruce et al., Nature 389, 498 (1997).
-
(1997)
Nature
, vol.389
, pp. 498
-
-
Bruce, M.E.1
-
8
-
-
0033600407
-
-
J. Collinge, Lancet 354, 317 (1999).
-
(1999)
Lancet
, vol.354
, pp. 317
-
-
Collinge, J.1
-
9
-
-
33745440706
-
-
J. Collinge et al., Lancet 367, 2068 (2006).
-
(2006)
Lancet
, vol.367
, pp. 2068
-
-
Collinge, J.1
-
10
-
-
33845227845
-
-
S. J. Wroe et al., Lancet 368, 2061 (2006).
-
(2006)
Lancet
, vol.368
, pp. 2061
-
-
Wroe, S.J.1
-
14
-
-
3442889359
-
-
G. Legname et al., Science 305, 673 (2004).
-
(2004)
Science
, vol.305
, pp. 673
-
-
Legname, G.1
-
15
-
-
0001074386
-
-
C. J. Gajdusek, C. J. Gibbs, M. P. Alpers, Eds, U.S. Government Printing Office, Washington, DC
-
I. H. Pattison, in Slow, Latent and Temperate Virus Infections, NINDB Monograph 2, C. J. Gajdusek, C. J. Gibbs, M. P. Alpers, Eds. (U.S. Government Printing Office, Washington, DC, 1965), pp. 249-257.
-
(1965)
Slow, Latent and Temperate Virus Infections, NINDB Monograph
, vol.2
, pp. 249-257
-
-
Pattison, I.H.1
-
16
-
-
0025244011
-
-
S. B. Prusiner et al., Cell 63, 673 (1990).
-
(1990)
Cell
, vol.63
, pp. 673
-
-
Prusiner, S.B.1
-
18
-
-
0025820942
-
-
M. S. Palmer, A. J. Dryden, J. T. Hughes, J. Collinge, Nature 352, 340 (1991).
-
(1991)
Nature
, vol.352
, pp. 340
-
-
Palmer, M.S.1
Dryden, A.J.2
Hughes, J.T.3
Collinge, J.4
-
20
-
-
13344293718
-
-
J. Collinge et al., Nature 378, 779 (1995).
-
(1995)
Nature
, vol.378
, pp. 779
-
-
Collinge, J.1
-
25
-
-
12644272790
-
-
G. C. Telling et al., Science 274, 2079 (1996).
-
(1996)
Science
, vol.274
, pp. 2079
-
-
Telling, G.C.1
-
26
-
-
0031720905
-
-
J. Safar et al., Nat. Med. 4, 1157 (1998).
-
(1998)
Nat. Med
, vol.4
, pp. 1157
-
-
Safar, J.1
-
30
-
-
0027956109
-
-
D. A. Kocisko et al., Nature 370, 471 (1994).
-
(1994)
Nature
, vol.370
, pp. 471
-
-
Kocisko, D.A.1
-
31
-
-
0028997297
-
-
R. A. Bessen et al., Nature 375, 698 (1995).
-
(1995)
Nature
, vol.375
, pp. 698
-
-
Bessen, R.A.1
-
32
-
-
17444413067
-
-
J. Castilla, P. Saa, C. Hetz, C. Soto, Cell 121, 195 (2005).
-
(2005)
Cell
, vol.121
, pp. 195
-
-
Castilla, J.1
Saa, P.2
Hetz, C.3
Soto, C.4
-
34
-
-
0028052363
-
-
D. Westaway et al., Cell 76, 117 (1994).
-
(1994)
Cell
, vol.76
, pp. 117
-
-
Westaway, D.1
-
35
-
-
84888732359
-
-
Our unpublished data with aged tga20 mice
-
Our unpublished data with aged tga20 mice.
-
-
-
-
37
-
-
22744448690
-
-
K. E. Nazor et al., EMBO J. 24, 2472 (2005).
-
(2005)
EMBO J
, vol.24
, pp. 2472
-
-
Nazor, K.E.1
-
38
-
-
84888650990
-
-
In these experiments, 30 μl of PrP (0.5 mg/ml) was inoculated, which equates to >1014 molecules. An infectious unit of bona fide prion material approximates to 104 to 105 PrP molecules. Therefore, if composed primarily of infectious material, such a synthetic prion inoculum would contain 109 to 1010 infectious units. If dilution of the synthetic prion inoculum 10-fold resulted in no transmissions, this would imply <10 infectious units per undiluted inoculum and therefore that prions composed <1 in 10-8 of the material
-
-8 of the material.
-
-
-
-
41
-
-
1642633056
-
-
M. Tanaka, P. Chien, N. Naber, R. Cooke, J. S. Weissman, Nature 428, 323 (2004).
-
(2004)
Nature
, vol.428
, pp. 323
-
-
Tanaka, M.1
Chien, P.2
Naber, N.3
Cooke, R.4
Weissman, J.S.5
-
43
-
-
22544450457
-
-
R. Diaz-Avalos, C. Y. King, J. Wall, M. Simon, D. L. Caspar, Proc. Natl. Acad. Sci. U.S.A. 102, 10165 (2005).
-
(2005)
Proc. Natl. Acad. Sci. U.S.A
, vol.102
, pp. 10165
-
-
Diaz-Avalos, R.1
King, C.Y.2
Wall, J.3
Simon, M.4
Caspar, D.L.5
-
44
-
-
17044435107
-
-
M. Tanaka, P. Chien, K. Yonekura, J. S. Weissman, Cell 121, 49 (2005).
-
(2005)
Cell
, vol.121
, pp. 49
-
-
Tanaka, M.1
Chien, P.2
Yonekura, K.3
Weissman, J.S.4
-
47
-
-
33746698975
-
-
M. Tanaka, S. R. Collins, B. H. Toyama, J. S. Weissman, Nature 442, 585 (2006).
-
(2006)
Nature
, vol.442
, pp. 585
-
-
Tanaka, M.1
Collins, S.R.2
Toyama, B.H.3
Weissman, J.S.4
-
52
-
-
18744362997
-
-
E. A. Asante et al., EMBO J. 21, 6358 (2002).
-
(2002)
EMBO J
, vol.21
, pp. 6358
-
-
Asante, E.A.1
-
57
-
-
0031765497
-
-
D. M. Taylor, K. Fernie, I. McConnell, P. J. Steele, Vet. Microbiol. 64, 33 (1998).
-
(1998)
Vet. Microbiol
, vol.64
, pp. 33
-
-
Taylor, D.M.1
Fernie, K.2
McConnell, I.3
Steele, P.J.4
-
58
-
-
0001770148
-
-
S. B. Prusiner, J. Collinge, J. Powell, B. Anderton, Eds, Horwood, London, chap. 22
-
H. Fraser, M. E. Bruce, D. Davies, C. F. Farguhar, P. A. McBride, in Prion Diseases of Humans and Animals, S. B. Prusiner, J. Collinge, J. Powell, B. Anderton, Eds. (Horwood, London, 1992), chap. 22.
-
(1992)
Prion Diseases of Humans and Animals
-
-
Fraser, H.1
Bruce, M.E.2
Davies, D.3
Farguhar, C.F.4
McBride, P.A.5
-
59
-
-
0032578283
-
-
D. A. Hilton, E. Fathers, P. Edwards, J. W. Ironside, J. Zajicek, Lancet 352, 703 (1998).
-
(1998)
Lancet
, vol.352
, pp. 703
-
-
Hilton, D.A.1
Fathers, E.2
Edwards, P.3
Ironside, J.W.4
Zajicek, J.5
-
60
-
-
0033573778
-
-
A. F. Hill et al., Lancet 353, 183 (1999).
-
(1999)
Lancet
, vol.353
, pp. 183
-
-
Hill, A.F.1
-
62
-
-
0026600865
-
-
H. Bueler et al., Nature 356, 577 (1992).
-
(1992)
Nature
, vol.356
, pp. 577
-
-
Bueler, H.1
-
63
-
-
0036470471
-
-
G. R. Mallucci et al., EMBO J. 21, 202 (2002).
-
(2002)
EMBO J
, vol.21
, pp. 202
-
-
Mallucci, G.R.1
-
64
-
-
0027319326
-
-
H. Bueler et al., Cell 73, 1339 (1993).
-
(1993)
Cell
, vol.73
, pp. 1339
-
-
Bueler, H.1
-
65
-
-
0028703452
-
-
J. C. Manson, A. R. Clarke, P. A. McBride, I. McConnell, J. Hope, Neurodegeneration 3, 331 (1994).
-
(1994)
Neurodegeneration
, vol.3
, pp. 331
-
-
Manson, J.C.1
Clarke, A.R.2
McBride, P.A.3
McConnell, I.4
Hope, J.5
-
66
-
-
0027483615
-
-
G. Forloni et al., Nature 362, 543 (1993).
-
(1993)
Nature
, vol.362
, pp. 543
-
-
Forloni, G.1
-
67
-
-
0142105406
-
-
C. Hetz, M. Russelakis-Carneiro, K. Maundrell, J. Castilla, C. Soto, EMBO J. 22, 5435 (2003).
-
(2003)
EMBO J
, vol.22
, pp. 5435
-
-
Hetz, C.1
Russelakis-Carneiro, M.2
Maundrell, K.3
Castilla, J.4
Soto, C.5
-
68
-
-
0029160006
-
-
J. Collinge et al., Lancet 346, 569 (1995).
-
(1995)
Lancet
, vol.346
, pp. 569
-
-
Collinge, J.1
-
69
-
-
0026690906
-
-
R. Medori et al., Neurology 42, 669 (1992).
-
(1992)
Neurology
, vol.42
, pp. 669
-
-
Medori, R.1
-
70
-
-
0025681138
-
-
K. K. Hsiao et al., Science 250, 1587 (1990).
-
(1990)
Science
, vol.250
, pp. 1587
-
-
Hsiao, K.K.1
-
72
-
-
0028343093
-
-
A. Sailer, H. Bueler, M. Fischer, A. Aguzzi, C. Weissmann, Cell 77, 967 (1994).
-
(1994)
Cell
, vol.77
, pp. 967
-
-
Sailer, A.1
Bueler, H.2
Fischer, M.3
Aguzzi, A.4
Weissmann, C.5
-
73
-
-
0030054010
-
-
S. Brandner et al., Nature 379, 339 (1996).
-
(1996)
Nature
, vol.379
, pp. 339
-
-
Brandner, S.1
-
74
-
-
0242363656
-
-
G. Mallucci et al., Science 302, 871 (2003).
-
(2003)
Science
, vol.302
, pp. 871
-
-
Mallucci, G.1
-
75
-
-
33846538022
-
-
G. R. Mallucci et al., Neuron 53, 325 (2007).
-
(2007)
Neuron
, vol.53
, pp. 325
-
-
Mallucci, G.R.1
-
76
-
-
12144291519
-
-
L. Solforosi et al., Science 313, 1514 (2004).
-
(2004)
Science
, vol.313
, pp. 1514
-
-
Solforosi, L.1
-
77
-
-
0032488777
-
-
R. S. Hegde et al., Science 279, 827 (1998).
-
(1998)
Science
, vol.279
, pp. 827
-
-
Hegde, R.S.1
-
79
-
-
20344394154
-
-
B. Chesebro et al., Science 308, 1435 (2005).
-
(2005)
Science
, vol.308
, pp. 1435
-
-
Chesebro, B.1
-
81
-
-
0034790796
-
-
R. Race, A. Raines, G. J. Raymond, B. Caughey, B. Chesebro, J. Virol. 75, 10106 (2001).
-
(2001)
J. Virol
, vol.75
, pp. 10106
-
-
Race, R.1
Raines, A.2
Raymond, G.J.3
Caughey, B.4
Chesebro, B.5
-
83
-
-
0029863648
-
-
M. Fischer et al., EMBO J. 15, 1255 (1996).
-
(1996)
EMBO J
, vol.15
, pp. 1255
-
-
Fischer, M.1
-
86
-
-
84888721310
-
-
L remains hypothetical and cannot yet be assayed directly.
-
L remains hypothetical and cannot yet be assayed directly.
-
-
-
-
87
-
-
84888710999
-
-
We are grateful to J. Wadsworth for discussion and to R. Young for preparation of figures. J.C. is a director of, and both J.C. and A.R.C. are shareholders in, D-Gen Ltd, a research-based biomedical company that identifies, develops, and exploits proprietary diagnostic and therapeutic targets and technologies for prion-related diseases
-
We are grateful to J. Wadsworth for discussion and to R. Young for preparation of figures. J.C. is a director of, and both J.C. and A.R.C. are shareholders in, D-Gen Ltd., a research-based biomedical company that identifies, develops, and exploits proprietary diagnostic and therapeutic targets and technologies for prion-related diseases.
-
-
-
|